Hogan Lovells represented Lockheed Martin in this transaction. Lockheed Martin [NYSE: LMT] signed a definitive agreement to acquire Terran Orbital [NYSE: LLAP], a global leader of...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised HLS Therapeutics Inc. on the deal. HLS Therapeutics Inc. (TSX: HLS) sold its royalty interest and milestone payment obligations in the global...
You must be a Standard 1 Year member to access this content.
Hogan Lovells represented Celonis in the transaction. Celonis, the global leader in execution management, has secured an additional $1 billion in funds to accelerate its unique position...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised OncoResponse on the deal. OncoResponse, a clinical-stage biotech company advancing immunotherapies for the treatment of cancer patients, closed a $50 million senior...
You must be a Standard 1 Year member to access this content.
